Cargando…

Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria

Adverse drug reactions (ADRs) are expected to be associated with an economic drain on the healthcare systems. The study was carried out to determine the occurrence of ADRs reported to NAFDAC Pharmacovigilance from January to June 2015, to illustrate the pattern of organ system affected by ADRs, to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Awodele, Olufunsho, Aliu, Rebecca, Ali, Ibrahim, Oni, Yetunde, Adeyeye, Christianah Mojisola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175912/
https://www.ncbi.nlm.nih.gov/pubmed/30324768
http://dx.doi.org/10.1002/prp2.427
_version_ 1783361593846792192
author Awodele, Olufunsho
Aliu, Rebecca
Ali, Ibrahim
Oni, Yetunde
Adeyeye, Christianah Mojisola
author_facet Awodele, Olufunsho
Aliu, Rebecca
Ali, Ibrahim
Oni, Yetunde
Adeyeye, Christianah Mojisola
author_sort Awodele, Olufunsho
collection PubMed
description Adverse drug reactions (ADRs) are expected to be associated with an economic drain on the healthcare systems. The study was carried out to determine the occurrence of ADRs reported to NAFDAC Pharmacovigilance from January to June 2015, to illustrate the pattern of organ system affected by ADRs, to assess the completeness of ADR report, to determine the relationship between the occurrence of ADRs with suspect drugs and the use of concomitant drugs as well as to generate possible signals from the reported ADRs. A total number of 921 ADR cases reported from January to June 2015 were analyzed using SPSS version 22. A higher percentage of ADR reports were seen in females (65.5%). The highest percentages of reports (45.6%) were from the age range of 21‐40 years, most of the suspected drugs reported had both NAFDAC (50.2%) and batch number identification (65.6%). HIV (56.9%) was the most prevalent indication reported for using the suspected drug; Zidovudine/Lamivudine/Nevirapine combination (16.9%) was reported as the suspected drug with the highest occurrences of ADRs and generalized body itching (6.9%) as the most prevalent ADR. “General disorders” (47.3%) was the most predominant organ system affected by ADRs and Pharmacists were revealed as the highest reporters of ADRs (80.2%). Overall, patients on ARVs should be vigilantly followed up as they are mostly prone to ADRs. Adverse drug reaction reporting systems need to be robust and complete in order to be able to detect new drug alerts, possible signals and improve pharmacovigilance
format Online
Article
Text
id pubmed-6175912
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61759122018-10-18 Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria Awodele, Olufunsho Aliu, Rebecca Ali, Ibrahim Oni, Yetunde Adeyeye, Christianah Mojisola Pharmacol Res Perspect Original Articles Adverse drug reactions (ADRs) are expected to be associated with an economic drain on the healthcare systems. The study was carried out to determine the occurrence of ADRs reported to NAFDAC Pharmacovigilance from January to June 2015, to illustrate the pattern of organ system affected by ADRs, to assess the completeness of ADR report, to determine the relationship between the occurrence of ADRs with suspect drugs and the use of concomitant drugs as well as to generate possible signals from the reported ADRs. A total number of 921 ADR cases reported from January to June 2015 were analyzed using SPSS version 22. A higher percentage of ADR reports were seen in females (65.5%). The highest percentages of reports (45.6%) were from the age range of 21‐40 years, most of the suspected drugs reported had both NAFDAC (50.2%) and batch number identification (65.6%). HIV (56.9%) was the most prevalent indication reported for using the suspected drug; Zidovudine/Lamivudine/Nevirapine combination (16.9%) was reported as the suspected drug with the highest occurrences of ADRs and generalized body itching (6.9%) as the most prevalent ADR. “General disorders” (47.3%) was the most predominant organ system affected by ADRs and Pharmacists were revealed as the highest reporters of ADRs (80.2%). Overall, patients on ARVs should be vigilantly followed up as they are mostly prone to ADRs. Adverse drug reaction reporting systems need to be robust and complete in order to be able to detect new drug alerts, possible signals and improve pharmacovigilance John Wiley and Sons Inc. 2018-10-08 /pmc/articles/PMC6175912/ /pubmed/30324768 http://dx.doi.org/10.1002/prp2.427 Text en © 2018 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Awodele, Olufunsho
Aliu, Rebecca
Ali, Ibrahim
Oni, Yetunde
Adeyeye, Christianah Mojisola
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
title Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
title_full Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
title_fullStr Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
title_full_unstemmed Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
title_short Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
title_sort patterns of adverse drug reaction signals in nafdac pharmacovigilance activities from january to june 2015: safety of drug use in nigeria
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175912/
https://www.ncbi.nlm.nih.gov/pubmed/30324768
http://dx.doi.org/10.1002/prp2.427
work_keys_str_mv AT awodeleolufunsho patternsofadversedrugreactionsignalsinnafdacpharmacovigilanceactivitiesfromjanuarytojune2015safetyofdruguseinnigeria
AT aliurebecca patternsofadversedrugreactionsignalsinnafdacpharmacovigilanceactivitiesfromjanuarytojune2015safetyofdruguseinnigeria
AT aliibrahim patternsofadversedrugreactionsignalsinnafdacpharmacovigilanceactivitiesfromjanuarytojune2015safetyofdruguseinnigeria
AT oniyetunde patternsofadversedrugreactionsignalsinnafdacpharmacovigilanceactivitiesfromjanuarytojune2015safetyofdruguseinnigeria
AT adeyeyechristianahmojisola patternsofadversedrugreactionsignalsinnafdacpharmacovigilanceactivitiesfromjanuarytojune2015safetyofdruguseinnigeria